Assembled from the company's filings and exchange data as of today. Download PDF renders this page on the server; the narrative sections arrive with the Nexa composer.
Dossier · BROACH LIFECARE HOSPITAL LIMIT · 28 October 2026Page 1 of 3
Company Dossier
MarketPing Research · factual · no rating expressed
BROACH LIFECARE HOSPITAL LIMIT
BSE: 544231
Healthcare › Healthcare › Healthcare Services › Hospital

BROACH LIFECARE HOSPITAL LIMIT

StateQ4 FY26 filed
Last close · 27 Oct 2026₹12.70
Market cap₹0.0k cr
TTM P/E · P/B · EV/EBITDA3.9 · — · —

Operates a hospital in Bharuch, Gujarat, providing healthcare services to patients. The Bharuch facility's bed capacity has doubled following a Permanent Clinical Establishment registration, taking total bed capacity from 40 to 65. Revenue from operations for FY26 reached Rs 599.47 lakhs, up from Rs 322.52 lakhs in FY25. The company is listed on the BSE SME platform and is deploying its IPO proceeds to purchase medical equipment and build a medical tourism portal. A Cath Lab Machine is being procured through a related-party arrangement (with the Managing Director's Heart Hospital) to meet Gujarat government empanelment norms under the AB PMJAY scheme for cardiology services. On the cost side, "other operating expenses" form the largest cost line at 45.5% of revenue, with employee costs at 19.3% and materials at 3.1%; capex was 54.7% of revenue in FY26, reflecting the ongoing capacity build-out. AR · MarketPing reader · 2026-08-02

Revenue streams, as the annual report describes them. Hospital and healthcare services. Small-cap, single-location hospital operator; recently IPO'd on BSE SME; in active capacity expansion phase

What a broker report prints here — the analyst's thesis. This dossier prints the filed record instead; the narrative read of the latest results, the guidance ledger and the earnings-call summary are the composer's sections (INSTITUTIONAL-PLAN.md M3) and are not yet produced.

Exhibit 1: Financial summary, FY25–FY26 (all audited; no estimate years)

₹ crore · standaloneFY25FY26
Revenue36
EBITDA (ex other income)——
margin %——
Owners' profit——
EPS, as reported (₹)0.980.14
ROE % · ROCE %— · 7.9— · 2.6
Debt / equity (x)——
Cash from operations(1)1
Capex(0)(3)
Source: SEBI results XBRL as filed with BSE/NSE; EBITDA excludes other income.
Every figure is a filed number or a ratio over filed numbers · No rating, target or fair value is expressed · Disclosures on the last pagemarketping.in
Dossier · BROACH LIFECARE HOSPITAL LIMIT · 28 October 2026Page 2 of 3

Exhibit 2: Quarterly performance, last 4 quarters

₹ croreQ2 FY25Q4 FY25Q2 FY26Q4 FY26
Revenue2133
Profit before tax100(0)
Net profit————
EPS (₹)1.700.171.030.37
Source: quarterly results as filed; the balance sheet is filed half-yearly and is not repeated here.

Exhibit 3: Peers — basic industry group, by market cap

CompanyM.cap ₹ crP/EP/BEV/EBITDAROE %ROCE %Rev CAGR 5y %EBITDA m. %
APOLLO HOSPITALS ENTER. L1,12,04253.611.2329.620.116.619.016.2
MAX HEALTHCARE INS LTD82,23956.47.6536.113.411.127.327.0
FORTIS HEALTHCARE LTD55,60353.15.4727.510.59.717.822.0
NARAYANA HRUDAYALAYA LTD.35,04842.77.7223.517.89.225.018.8
ASTER DM QUALITY CARE LTD34,204106.87.0834.98.88.5(11.6)14.3
GLOBAL HEALTH LIMITED33,86560.98.5034.413.913.5—23.7
KRISHNA INST OF MED SCI L29,211136.411.4239.79.55.124.020.3
DR AGARWALS HEALTH CARE L15,073101.47.1124.67.97.1—28.8
Source: exchange data and filed statements via the screener; multiples at current prices.

Exhibit 4: Where the company sits in its group

MetricCompanyGroup medianRankBetter than
P/E (TTM)3.942.22 of 3097%
ROCE2.210.926 of 3014%
Market cap8248130 of 300%
Source: MarketPing peer ranks; a rank is a measurement, not a view.
Every figure is a filed number or a ratio over filed numbers · No rating, target or fair value is expressed · Disclosures on the last pagemarketping.in
Dossier · BROACH LIFECARE HOSPITAL LIMIT · 28 October 2026Page 3 of 3

Exhibit 5: Filings of the last 90 days, with the measured price reaction

Date · filingCategoryImportanceNext day %5-day %
13 Oct 2026 · RTA certificate under SEBI Reg 74(5) for quarter ended Sep 30, 2026complianceminimal——
5 Oct 2026 · Maple Hospital gets ONGC and ESIC empanelment, awaits NABH certificationbusiness updatesmedium——
2 Oct 2026 · Broach Lifecare Hospital: All 3 resolutions passed at 3rd AGMboard shareholder meetingslow——
30 Sept 2026 · Secretarial auditor appointed for five yearsmanagement changeslow——
30 Sept 2026 · Broach Lifecare Hospital holds 3rd AGM, no dividend declaredboard shareholder meetingslow——
11 Sept 2026 · CFO of Broach Lifecare resigns; company clarifies BSE query on disclosuremanagement changeshigh——
9 Sept 2026 · AGM notice and annual report link sent to shareholders without registered emailcomplianceminimal——
9 Sept 2026 · Newspaper publication notice for 3rd Annual General Meetingcomplianceminimal——
8 Sept 2026 · Annual Report FY2025-26 and 3rd AGM notice filed with BSEresultsmedium——
8 Sept 2026 · Notice of 3rd AGM on September 30, 2026 with e-voting facilityboard shareholder meetingslow——
Source: exchange announcements; each reaction is measured from the close before the filing. Next day = the close one session after the reaction day (the first session that could trade the filing).

How to read this document

Where a broker report showsThis document showsWhy
A rating (BUY / ADD / REDUCE / SELL)A state: the latest filed quarter and the measured reactionsan event is a fact; a rating is an opinion that requires SEBI RA registration
A target price and upsideThe current price and the multiples against the groupa target is a forecast; a multiple is a measurement
Estimate years marked EMore audited years; no estimatesMarketPing publishes no forecasts — your own model lives on the Models page

Sources, method and disclosures

This document is a statistical summary of publicly filed information and market data, prepared by software from primary sources: SEBI results XBRL filed with BSE and NSE, LODR disclosures, shareholding patterns, exchange price data. It contains no research recommendation, no price target and no opinion on the merits of any security, and is not a research report within the meaning of the SEBI (Research Analysts) Regulations, 2014, Regulation 2(1)(w)(vii). Financial statements are as filed (consolidated where the company files consolidated results). Ratios are computed over filed lines. Where a figure is unavailable the table shows a dash rather than an estimate. The business brief is written by MarketPing's reader from the annual report and checked against it; no figure in a table was generated by a model. Nothing here constitutes investment advice, an offer or a solicitation; readers should consult a SEBI-registered adviser before acting. MarketPing is not a SEBI-registered intermediary.

Every figure is a filed number or a ratio over filed numbers · No rating, target or fair value is expressed · Disclosures on the last pagemarketping.in